The delayed addition of human mesenchymal stem cells to pre-formed endothelial cell networks results in functional vascularization of a collagen-glycosaminoglycan scaffold in vivo

被引:99
作者
McFadden, T. M. [1 ,2 ]
Duffy, G. P. [1 ,2 ,3 ,4 ]
Allen, A. B. [5 ]
Stevens, H. Y. [5 ]
Schwarzmaier, S. M. [6 ]
Plesnila, N. [6 ]
Murphy, J. M. [7 ]
Barry, F. P. [7 ]
Guldberg, R. E. [5 ]
O'Brien, F. J. [1 ,2 ,3 ,4 ]
机构
[1] Royal Coll Surgeons Ireland, Tissue Engn Res Grp, Dublin 2, Ireland
[2] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland
[3] Royal Coll Surgeons Ireland, Adv Mat & BioEngn Res AMBER Ctr, Dublin 2, Ireland
[4] Trinity Coll Dublin, Dublin, Ireland
[5] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA
[6] Royal Coll Surgeons Ireland, Dept Neurodegenerat, Dublin 2, Ireland
[7] Natl Univ Ireland Galway, Regenerat Med Inst, Galway, Ireland
基金
欧洲研究理事会; 爱尔兰科学基金会;
关键词
Mesenchymal stem cells; Endothelial cells; Co-culture; Collagen GAG scaffold; In vivo vascularization; HUMAN BONE-MARROW; PROGENITOR CELLS; BLOOD-VESSELS; STROMAL CELLS; GROWTH-FACTOR; CORD BLOOD; ADULT; VITRO; ANGIOGENESIS; INOSCULATION;
D O I
10.1016/j.actbio.2013.08.014
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This paper demonstrates a method to engineer, in vitro, a nascent microvasculature within a collagen-glycosaminoglycan scaffold with a view to overcoming the major issue of graft failure due to avascular necrosis of tissue-engineered constructs. Human umbilical vein endothelial cells (ECs) were cultured alone and in various co-culture combinations with human mesenchymal stem cells (MSCs) to determine their vasculogenic abilities in vitro. Results demonstrated that the delayed addition of MSCs to preformed EC networks, whereby MSCs act as pericytes to the nascent vessels, resulted in the best developed vasculature. The results also demonstrate that the crosstalk between ECs and MSCs during microvessel formation occurs in a highly regulated, spatio-temporal fashion, whereby the initial seeding of ECs results in platelet derived growth factor (PDGF) release; the subsequent addition of MSCs 3 days later leads to a cessation in PDGF production, coinciding with increased vascular endothelial cell growth factor expression and enhanced vessel formation. Functional assessment of these pre-engineered constructs in a subcutaneous rat implant model demonstrated anastomosis between the in vitro engineered vessels and the host vasculature, with significantly increased vascularization occurring in the co-culture group. This study has thus provided new information on the process of in vitro vasculogenesis within a three-dimensional porous scaffold for tissue engineering and demonstrates the potential for using these vascularized scaffolds in the repair of critical sized bone defects. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:9303 / 9316
页数:14
相关论文
共 67 条
[1]   Evaluation of the ability of collagen-glycosaminoglycan scaffolds with or without mesenchymal stem cells to heal bone defects in Wistar rats [J].
M. Alhag ;
E. Farrell ;
M. Toner ;
T. Clive Lee ;
F. J. O’Brien ;
N. Claffey .
Oral and Maxillofacial Surgery, 2012, 16 (1) :47-55
[2]   Evaluation of early healing events around mesenchymal stem cell-seeded collagen-glycosaminoglycan scaffold. An experimental study in Wistar rats [J].
Alhag M. ;
Farrell E. ;
Toner M. ;
Claffey N. ;
Lee T.C. ;
O'Brien F. .
Oral and Maxillofacial Surgery, 2011, 15 (1) :31-39
[3]   Type I collagen, fibrin and PuraMatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks [J].
Allen, Patrick ;
Melero-Martin, Juan ;
Bischoff, Joyce .
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2011, 5 (04) :E74-E86
[4]   Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro [J].
Alviano, Francesco ;
Fossati, Valentina ;
Marchionni, Cosetta ;
Arpinati, Mario ;
Bonsi, Laura ;
Franchina, Michele ;
Lanzoni, Giacomo ;
Cantoni, Silvia ;
Cavallini, Claudia ;
Bianchi, Francesca ;
Tazzari, Pier Luigi ;
Pasquinelli, Gianandrea ;
Foroni, Laura ;
Ventura, Carlo ;
Grossi, Alberto ;
Bagnara, Gian Paolo .
BMC DEVELOPMENTAL BIOLOGY, 2007, 7
[5]   Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells [J].
Aslan, Hadi ;
Zilberman, Yoram ;
Kandel, Leonid ;
Liebergall, Meir ;
Oskouian, Rod J. ;
Gazit, Dan ;
Gazit, Zulma .
STEM CELLS, 2006, 24 (07) :1728-1737
[6]   Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature [J].
Au, Patrick ;
Tam, Joshua ;
Fukumura, Dai ;
Jain, Rakesh K. .
BLOOD, 2008, 111 (09) :4551-4558
[7]   Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels [J].
Au, Patrick ;
Daheron, Laurence M. ;
Duda, Dan G. ;
Cohen, Kenneth S. ;
Tyrrell, James A. ;
Lanning, Ryan M. ;
Fukumura, Dai ;
Scadden, David T. ;
Jain, Rakesh K. .
BLOOD, 2008, 111 (03) :1302-1305
[8]   A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors [J].
Briganti, Enrica ;
Spiller, Dario ;
Mirtelli, Chiara ;
Kull, Silvia ;
Counoupas, Claudio ;
Losi, Paola ;
Senesi, Sonia ;
Di Stefano, Rossella ;
Soldani, Giorgio .
JOURNAL OF CONTROLLED RELEASE, 2010, 142 (01) :14-21
[9]  
Butler MJ, 2012, TISSUE ENG PT A, V18, P1628, DOI [10.1089/ten.tea.2011.0467, 10.1089/ten.TEA.2011.0467]
[10]   Why are MSCs therapeutic? New data: new insight [J].
Caplan, Al .
JOURNAL OF PATHOLOGY, 2009, 217 (02) :318-324